UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 142

Sortiert nach

Impact of Therapy Persistence on Exacerbations and Resource Use in Patients Who Initiated COPD Therapy

International journal of chronic obstructive pulmonary disease, 2019-12, Vol.14, p.2905-2915

2019

Volltextzugriff (PDF)

COPD treatment pathways in France: a retrospective analysis of electronic medical record data from general practitioners

International journal of chronic obstructive pulmonary disease, 2019-01, Vol.14, p.51-63

2019

Volltextzugriff (PDF)

COPEDOL: A two-year observational study in pretreated HIV-1-infected patients switching to a dolutegravir-based regimen

Infectious diseases now (Online), 2022-03, Vol.52 (2), p.93-100

2022

Volltextzugriff (PDF)

Therapeutic adherence in chronic obstructive pulmonary disease: A literature review

Revue des maladies respiratoires, 2019-09, Vol.36 (7), p.801

2019

Volltextzugriff (PDF)

GSK256073, a selective agonist of G-protein coupled receptor 109A (GPR109A) reduces serum glucose in subjects with type 2 diabetes mellitus

Diabetes, obesity & metabolism, 2013-11, Vol.15 (11), p.1013-1021

2013

Volltextzugriff (PDF)

Benefit–Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit–Risk Models Applied to Vaccines

Drug safety, 2020-11, Vol.43 (11), p.1089-1104

2020

Volltextzugriff (PDF)

A Bayesian Dynamic Model of Asthma in the Real Life

Value in health, 2013-11, Vol.16 (7), p.A594-A595

2013

Volltextzugriff (PDF)

Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)

Drug safety, 2020-11, Vol.43 (11), p.1105-1120

2020

Volltextzugriff (PDF)

Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit–Risk Models: The Example of Rotavirus Vaccination in France

Clinical therapeutics, 2020-10, Vol.42 (10), p.1983-1991.e2

2020

Volltextzugriff (PDF)

Quantitative Benefit-Risk Models Used for Rotavirus Vaccination: A Systematic Review

Open forum infectious diseases, 2020-04, Vol.7 (4), p.ofaa087-ofaa087

2020

Volltextzugriff (PDF)

Costs associated with hospitalization in HIV-positive patients in France

AIDS (London), 2018-09, Vol.32 (14), p.2059-2066

2018

Volltextzugriff (PDF)

PRS55 - COST-EFFECTIVENESS OF MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA PATIENTS IN FRANCE

Value in health, 2018-10, Vol.21, p.S413-S413

2018

Volltextzugriff (PDF)

Identification des multithérapies inhalées dans le Système national des données de santé (SNDS) : exemple de l'étude REFRAIN dans la bronchopneumopathie obstructive

Revue d'épidémiologie et de santé publique, 2022-11, Vol.70, p.S269-S270

2022

Volltextzugriff (PDF)

P135 Effets comparés du Glimépiride et de la Rosiglitazone sur la dysglycémie et le stress oxydatif du diabète de type 2

Diabetes & metabolism, 2009, Vol.35, p.A60-A60

2009

Volltextzugriff (PDF)

Towards Better Coordination and More Efficient Patient Pathways in Copd

Value in health, 2016-11, Vol.19 (7), p.A611-A611

2016

Volltextzugriff (PDF)

PHS42 - Towards Better Coordination and More Efficient Patient Pathways in Copd

Value in health, 2016-11, Vol.19 (7), p.A611-A611

2016

Volltextzugriff (PDF)

PIN35 GLOBAL ANNUAL COSTS OF PEOPLE LIVING WITH HIV IN FRANCE IN 2013 FROM A NATIONAL INSURANCE CLAIMS DATABASE (SNIIRAM)

Value in health, 2019-11, Vol.22, p.S645-S646

2019

Volltextzugriff (PDF)

PIN105 DESCRIPTION OF PATIENTS HOSPITALIZED WITH MENINGOCOCCAL INFECTIONS IN FRANCE: AN ANALYSIS OF THE NATIONAL HEALTHCARE CLAIM(SNIIR-AM) DATABASE

Value in health, 2019-11, Vol.22, p.S656-S656

2019

Volltextzugriff (PDF)

PIN19 The Economic Burden of Invasive Meningococcal Disease in France: A Case-Control Retrospective Database Analysis

Value in health, 2020-12, Vol.23, p.S546-S546

2020

Volltextzugriff (PDF)

Caractéristiques et historique des soins précédant l’initiation en France de fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI)

Revue des maladies respiratoires actualités, 2023-01, Vol.15 (1), p.68

2023

Volltextzugriff (PDF)

PRS23 - PERSISTENCE TO COPD THERAPIES AND IMPACT ON COSTS RELATED TO HEALTHCARE CONSUMPTION: A FRENCH CLAIMS DATA STUDY

Value in health, 2018-10, Vol.21, p.S407-S407

2018

Volltextzugriff (PDF)

Economic Burden of Hospitalizations Related To Pulmonary Arterial Hypertension (PAH) In France

Value in health, 2017-10, Vol.20 (9), p.A609-A610

2017

Volltextzugriff (PDF)

Is it Possible to Accurately Identify Rare Diseases Using National Hospital Discharge Databases?

Value in health, 2017-10, Vol.20 (9), p.A741

2017

Volltextzugriff (PDF)

PCV53 - Economic Burden of Hospitalizations Related To Pulmonary Arterial Hypertension (PAH) In France

Value in health, 2017-10, Vol.20 (9), p.A609-A610

2017

Volltextzugriff (PDF)

PRM60 - Is it Possible to Accurately Identify Rare Diseases Using National Hospital Discharge Databases?

Value in health, 2017-10, Vol.20 (9), p.A741-A741

2017

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(124)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Life Sciences & Biomedicine
(74)
Humans
(65)
Male
(48)
Adult
(44)
Female
(44)
Middle Aged
(42)
Biological And Medical Sciences
(37)
Medical Sciences
(35)
Hematology
(32)
Aged
(23)
Adolescent
(22)
Immunology
(21)
Oncology
(18)
Retrospective Studies
(18)
Transplantation
(18)
Stem Cell Transplantation
(17)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(16)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(16)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of Therapy Persistence on Exacerbations and Resource Use in Patients Who Initiated COPD Therapy

COPD treatment pathways in France: a retrospective analysis of electronic medical record data from general practitioners

COPEDOL: A two-year observational study in pretreated HIV-1-infected patients switching to a dolutegravir-based regimen

Therapeutic adherence in chronic obstructive pulmonary disease: A literature review

GSK256073, a selective agonist of G-protein coupled receptor 109A (GPR109A) reduces serum glucose in subjects with type 2 diabetes mellitus

Benefit–Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit–Risk Models Applied to Vaccines

A Bayesian Dynamic Model of Asthma in the Real Life

Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)

Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit–Risk Models: The Example of Rotavirus Vaccination in France

Quantitative Benefit-Risk Models Used for Rotavirus Vaccination: A Systematic Review

Costs associated with hospitalization in HIV-positive patients in France

PRS55 - COST-EFFECTIVENESS OF MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA PATIENTS IN FRANCE

Identification des multithérapies inhalées dans le Système national des données de santé (SNDS) : exemple de l'étude REFRAIN dans la bronchopneumopathie obstructive

P135 Effets comparés du Glimépiride et de la Rosiglitazone sur la dysglycémie et le stress oxydatif du diabète de type 2

Towards Better Coordination and More Efficient Patient Pathways in Copd

PHS42 - Towards Better Coordination and More Efficient Patient Pathways in Copd

PIN35 GLOBAL ANNUAL COSTS OF PEOPLE LIVING WITH HIV IN FRANCE IN 2013 FROM A NATIONAL INSURANCE CLAIMS DATABASE (SNIIRAM)

PIN105 DESCRIPTION OF PATIENTS HOSPITALIZED WITH MENINGOCOCCAL INFECTIONS IN FRANCE: AN ANALYSIS OF THE NATIONAL HEALTHCARE CLAIM(SNIIR-AM) DATABASE

PIN19 The Economic Burden of Invasive Meningococcal Disease in France: A Case-Control Retrospective Database Analysis

Caractéristiques et historique des soins précédant l’initiation en France de fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI)

PRS23 - PERSISTENCE TO COPD THERAPIES AND IMPACT ON COSTS RELATED TO HEALTHCARE CONSUMPTION: A FRENCH CLAIMS DATA STUDY

Economic Burden of Hospitalizations Related To Pulmonary Arterial Hypertension (PAH) In France

Is it Possible to Accurately Identify Rare Diseases Using National Hospital Discharge Databases?

PCV53 - Economic Burden of Hospitalizations Related To Pulmonary Arterial Hypertension (PAH) In France

PRM60 - Is it Possible to Accurately Identify Rare Diseases Using National Hospital Discharge Databases?

Suchergebnisse filtern